Europe — EMA

Ondansetron Noridem Enterprises

Ondondansetron, the active ingredient in Ondansetron Noridem Enterprises, is a 5-HT3 receptor antagonist presented as a tablet for oral use.

Ondansetron

Request sourcing

Pack/s

What is Ondansetron?

Ondondansetron, the active ingredient in Ondansetron Noridem Enterprises, is a 5-HT3 receptor antagonist presented as a tablet for oral use. It helps prevent nausea and vomiting associated with chemotherapy, radiation therapy, and surgery in adult patients. GNH USA supplies Ondansetron Noridem Enterprises as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Ondansetron Noridem Enterprises as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Ondansetron used for?

Ondansetron is a selective 5‑HT3 receptor antagonist used in the management of nausea and vomiting pathways.

- Chemotherapy‑induced nausea and vomiting: Reduces the frequency and severity of CINV in adults and adolesc patients. - Radiation‑induced nausea and vomiting: Helps mit the symptoms of radiation‑related nausea. - Post‑operative post‑ post ....

What are the side effects of Ondansetron?

Common ...

What precautions apply to Ondansetron?

...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →